ALAN NGUYEN: Open Payments
NPI 1336628692 · TERRYTOWN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,211 in 41 payments from 7 companies in 2025. Trend: 2023 $932 · 2024 $1,400 · 2025 $1,211
Food & beverage: $1,211
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 10 | $269 |
| Otsuka America Pharmaceutical, Inc. | 6 | $220 |
| E.R. Squibb & Sons, L.L.C. | 5 | $203 |
| Alkermes, Inc. | 5 | $203 |
| Lundbeck LLC | 8 | $158 |
| Janssen Pharmaceuticals, Inc | 5 | $107 |
| Teva Pharmaceuticals USA, Inc. | 2 | $52 |
Products named: INGREZZA, ABILIFY ASIMTUFII, COBENFY, ABILIFY MAINTENA, LYBALVI, ARISTADA, INVEGA SUSTENNA, UZEDY.
Industry payments across LA — which companies pay providers there.
